A world leader in antibacterial & antiviral drug research and development
News
CARB-X funds VenatoRx Pharmaceuticals to support the development of a new class of oral antibiotics to treat multi-drug-resistant gonorrhea
November 25, 2019
VenatoRx Pharmaceuticals Names Joseph C. Larsen, Ph.D. Vice President, Strategic Portfolio Development
September 04, 2019
>> More News
Upcoming Events
J.P. Morgan Health Care Investor Conference 2020
Monday, January 13, 2020 - Thursday, January 16, 2020 San Francisco, CA
BIO CEO & Investor Conference 2020
Monday, February 10, 2020 - Tuesday, February 11, 2020 New York, NY
>> More Events
Pipeline